■ Correlação entre exercício físico e qualidade de vida em pacientes com doença de Alzheimer
M Kamada, J S Clemente, A F F Monteiro et al
Rev Soc Bras Clin Med 2018, vol 16 (2): 119-122
http://docs.bvsalud.org/biblioref/2018/09/913374/162119-122.pdf
■ Cognitive, functional and physical activity impairment in elderly with Alzheimer’s disease.
Pedroso, Renata Valle et al.
Dement. neuropsychol., Mar 2018, vol.12, no.1, p.28-34
■ Assessing fitness to drive in patients with different types os dementia
Dafne Piersma, Anselm B.M. Fuermaier, Dick De Waard et al
Alzheimer Dis Assoc Disord. 2018, vol 32(1): 70–75
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841853/
■ Alzheimer´s disease and blood-based biomarkers – potential contexts of use
Martina Zvěřová
Neuropsychiatr Dis Treat. 2018; 14: 1877–1882
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055879/
■ Cognitive blackouts in mild cognitive impairment and Alzheimer´s dementia
Georg Adler, Agnies Marczak, Jana Binder
Dement Geriatr Cogn Dis Extra. 2018 Jan-Apr; 8(1): 72–76
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5869359/
■ Alzheimer dementia: starting stopping drug therapy
L D Kim R M Factora
Cleveland Clinic Journal of Medicine 2018, vol 85: 209-214
■ Ocular manifestation of Alzhemier´s and other neurodegenerative diseases: the prospect of the eye as a tool for the early diagnosis of Alzheimer´s disease
P Colligris, M J P de Lara, B Colligris, J Pintor
Journal of Ophthalmology 2018, Article ID 8538573, 12 pages
https://www.hindawi.com/journals/joph/2018/8538573/
■ Strategies for continued successful treatment in patients with Alzheimer´s disease: an overview of switching between pharmacological agents
Rafael Blesa, Kazuhiro Toriyama, Kengo Ueda et al
Curr Alzheimer Res. 2018 Oct; 15(10): 964–974
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142408/
■ Associations of acetylcholinesterase inhibitor treatment with reduced mortality in Alzheimer´s disease: a retrospective survival analysis
C Mueller, G Perera, R D Hayes et AL
Age and Ageing 2018, vol 47 (1): 88-94
https://academic.oup.com/ageing/article/47/1/88/3887242
■ Health economic evalutations of non-pharmacological interventions for persons with dementia and their informal caregivers: a systematic review
Franziska Nickel, Janina Barth, Peter L. Kolominsky-Rabas
BMC Geriatr. 2018; 18: 69
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5845149/
■ Technology-based cognitive training and rehabilitation inverventions for individuals with cognitive impairment: a systematic review
Shaoqing Ge, Zheng Zhu, Bei Wu, Eleanor S. McConnell
BMC Geriatr. 2018; 18: 213
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6139138/
■ National dementia strategies: What should Canada Learn?
Selina Chow, Ronald Chow, Angela Wan et al
Can Geriatr J. 2018 Jun; 21(2): 173–209
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6028171/
■ Psychosocial interventions for Alzhemier´s disease cognitive symptoms: a Bayesian network meta-analysis
Y Duan, L Lu, J Chen et al
BMC Geriatrics 2018, vol 18: 175
https://bmcgeriatr.biomedcentral.com/articles/10.1186/s12877-018-0864-6
■ Systematic Review on resting-state EEC for Alzheimer´s disease diagnosis and progression assessment
Raymundo Cassani, Mar Estarellas, Rodrigo San-Martin et al
Dis Markers. 2018; 2018: 5174815
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6200063/
■ Flavonoids as therapeutic agents in Alzheimer´s and Parkinsons diseases: a systematic review of preclinical evidences
Roxana Braga de Andrade Teles, Tâmara Coimbra Diniz, Tiago Coimbra Costa Pinto et al
Oxid Med Cell Longev. 2018; 2018: 7043213
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5971291/
■ Neuroing characteristics of small-vessel disease in older adults with normal cognition, mild cognitive impairment, and Alzheimer disease
Alberto Mimenza-Alvarado, Sara G. Aguilar-Navarro, Sara Yeverino-Castro et al
Dement Geriatr Cogn Dis Extra. 2018, vol 8(2): 199–206
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006607/
■ Low expression of aging-relatedd NRXN3 is associated with Alzheimer disease
J Zheng, W Li, J Liu et al
Medicine (Baltimore) 2018, vol 97 (28): e11343
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6076205/
■ Validity and reliability of the Brazilian Portuguese version of the Australian National University – Alzheimer’s Disease Risk Index (ANU-ADRI).
Borges, Marcus Kiiti, Jacinto, Alessandro Ferrari and Citero, Vanessa Albuquerque
Dement. neuropsychol., Sept 2018, vol.12, no.3, p.235-243
■ Olfactory dysfunction in Alzheimer’s disease Systematic review and meta-analysis.
Silva, Maren de Moraes e et al.
Dement. neuropsychol., June 2018, vol.12, no.2, p.123-132
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1980-57642018000200123&lng=en&nrm=iso
■ Visual features in Alzheimer´s disease: from basic mechanism to clinical overview
M A Cerquera-Jaramillo, M O Nava-Mesa, R E González-Reyes et al
Neural Plasticity 2018, Article ID 2941783, 21 pages
https://www.hindawi.com/journals/np/2018/2941783/
■ Factors associated with quality of life in patients with Alzheimer´s disease
Coralie Barbe, Damien Jolly, Isabella Morrone et al
BMC Geriatr. 2018; 18: 159.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6038200/
by Dr Paulo Fernando Leite
■ Cardiologia/Prevenção Cardiovascular
■ Estratificação de Risco Cardiovascular
Av Contorno 8351 – Conj 01
Belo Horizonte/MG/Brasil
Tel: 31 32919216 2917003 3357229
(- consulta particular –)
CRMMG: 7026
Email: pfleite1873@gmail.com